- Home
- ONC vs BNTX Comparison
ONC vs BNTX Comparison
Compare ONC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- BNTX
- Stock Information
- Founded
- ONC 2010
- BNTX 2008
- Country
- ONC Switzerland
- BNTX Germany
- Employees
- ONC N/A
- BNTX N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONC Health Care
- BNTX Health Care
- Exchange
- ONC Nasdaq
- BNTX Nasdaq
- Market Cap
- ONC 26.9B
- BNTX 25.0B
- IPO Year
- ONC N/A
- BNTX 2019
- Fundamental
- Price
- ONC $245.58
- BNTX $108.82
- Analyst Decision
- ONC Strong Buy
- BNTX Strong Buy
- Analyst Count
- ONC 7
- BNTX 18
- Target Price
- ONC $326.43
- BNTX $142.27
- AVG Volume (30 Days)
- ONC 368.4K
- BNTX 896.4K
- Earning Date
- ONC 05-07-2025
- BNTX 05-05-2025
- Dividend Yield
- ONC N/A
- BNTX N/A
- EPS Growth
- ONC N/A
- BNTX N/A
- EPS
- ONC N/A
- BNTX N/A
- Revenue
- ONC $4,180,740,829.00
- BNTX $2,968,331,171.00
- Revenue This Year
- ONC $32.78
- BNTX N/A
- Revenue Next Year
- ONC $19.07
- BNTX $9.07
- P/E Ratio
- ONC N/A
- BNTX N/A
- Revenue Growth
- ONC 52.09
- BNTX 0.61
- 52 Week Low
- ONC $141.31
- BNTX $76.53
- 52 Week High
- ONC $287.88
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- BNTX 46.34
- Support Level
- ONC N/A
- BNTX $96.38
- Resistance Level
- ONC N/A
- BNTX $100.48
- Average True Range (ATR)
- ONC 0.00
- BNTX 3.44
- MACD
- ONC 0.00
- BNTX 0.24
- Stochastic Oscillator
- ONC 0.00
- BNTX 40.84
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.